HN2008001521A - Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica - Google Patents

Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica

Info

Publication number
HN2008001521A
HN2008001521A HN2008001521A HN2008001521A HN2008001521A HN 2008001521 A HN2008001521 A HN 2008001521A HN 2008001521 A HN2008001521 A HN 2008001521A HN 2008001521 A HN2008001521 A HN 2008001521A HN 2008001521 A HN2008001521 A HN 2008001521A
Authority
HN
Honduras
Prior art keywords
preparation
dimeros
therapeutics
application
artemisinine
Prior art date
Application number
HN2008001521A
Other languages
English (en)
Inventor
Commercon Alain
Zhang Jidong
Httinger Augustin
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of HN2008001521A publication Critical patent/HN2008001521A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/04—Seven-membered rings not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/04—Seven-membered rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
    • C07D323/04—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings

Abstract

LA PRESENTA INVENCION SE REFIERE A NUEVOS DIMEROS DE DERIVADOS DE ARTEMISININA ESPECIFICOS, SU PREPARACION, COMPOSICIONES QUE LOS CONTIENE Y SU UTILIZACION COMO MEDICAMNETOS, EN PARTICULAR COMO AGENTES ANTICANCERIGENOS
HN2008001521A 2006-04-11 2008-10-03 Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica HN2008001521A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0603209A FR2899586B1 (fr) 2006-04-11 2006-04-11 Dimeres de derives d'artemisinine, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
HN2008001521A true HN2008001521A (es) 2011-04-25

Family

ID=37429238

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2008001521A HN2008001521A (es) 2006-04-11 2008-10-03 Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica

Country Status (40)

Country Link
US (1) US8314142B2 (es)
EP (1) EP2007769B1 (es)
JP (1) JP5265518B2 (es)
KR (1) KR101357523B1 (es)
CN (1) CN101421276B (es)
AR (1) AR060400A1 (es)
AT (1) ATE512970T1 (es)
AU (1) AU2007235813B2 (es)
BR (1) BRPI0710152A2 (es)
CA (1) CA2641138C (es)
CR (1) CR10247A (es)
CY (1) CY1111833T1 (es)
DK (1) DK2007769T3 (es)
EA (1) EA015607B1 (es)
EC (1) ECSP088792A (es)
ES (1) ES2367715T3 (es)
FR (1) FR2899586B1 (es)
GT (1) GT200800206A (es)
HK (1) HK1131779A1 (es)
HN (1) HN2008001521A (es)
HR (1) HRP20110654T1 (es)
IL (1) IL194655A0 (es)
JO (1) JO2721B1 (es)
MA (1) MA30410B1 (es)
ME (1) ME00094B (es)
MX (1) MX2008012732A (es)
MY (1) MY154970A (es)
NO (1) NO20084352L (es)
NZ (1) NZ571342A (es)
PE (1) PE20080055A1 (es)
PL (1) PL2007769T3 (es)
PT (1) PT2007769E (es)
RS (1) RS51952B (es)
SI (1) SI2007769T1 (es)
TN (1) TNSN08321A1 (es)
TW (1) TWI423979B (es)
UA (1) UA94744C2 (es)
UY (1) UY30276A1 (es)
WO (1) WO2007116135A1 (es)
ZA (1) ZA200808025B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2925495B1 (fr) * 2007-12-21 2010-09-10 Pf Medicament Derives dimeriques d'artemisinine et application en therapie anticancereuse
FR2934593B1 (fr) * 2008-07-29 2010-09-10 Pf Medicament Derives dimeriques d'artemisinine et application en therapie anticancereuse
WO2011071981A2 (en) * 2009-12-08 2011-06-16 The Johns Hopkins University Anti-cytomegalovirus activity of artemisinin-derived dimers
US8815942B2 (en) 2010-10-20 2014-08-26 The Royal Institution For The Advancement Of Learning/Mcgill University Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease
CN102010422B (zh) * 2010-11-23 2014-11-26 沈阳药科大学 含有胍基的青蒿素类衍生物及其应用
CN102614168A (zh) * 2011-01-31 2012-08-01 上海交通大学医学院附属瑞金医院 一种青蒿素衍生物及其药用盐的应用
WO2012111025A2 (en) * 2011-02-14 2012-08-23 Council Of Scientific & Industrial Research 1,2,3-triazole containing artemisinin compounds and process for preparation thereof
CN103570738B (zh) * 2012-08-07 2016-04-13 中国科学院上海生命科学研究院 新型青蒿素衍生物及其制法和应用
CN106928274B (zh) * 2017-02-28 2019-09-10 东南大学 一种双氢青蒿素二倍体衍生物、其药物组合物及应用
CN110240605B (zh) * 2018-03-08 2021-12-31 中国科学院上海药物研究所 青蒿素二聚物的制备方法
CN109467565B (zh) * 2018-08-16 2020-07-10 云白药征武科技(上海)有限公司 双氢青蒿素三聚体及其制备方法和应用
EP3911311A4 (en) * 2019-02-26 2023-01-25 Mahmoud A. Elsohly SELECTED ARTEMISININ DIMERS FOR THE TREATMENT OF LEISHMANIA
CN117285548A (zh) * 2022-06-16 2023-12-26 云南苏理生物医药科技有限公司 一种含硫类青蒿素二聚体、其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1084333C (zh) 1998-06-17 2002-05-08 中国科学院上海药物研究所 新的青蒿素化合物,其制备方法以及含有它们的药物组合物
FR2831538B1 (fr) * 2001-10-26 2004-01-16 Centre Nat Rech Scient Nouveaux derives de l'artemisinine, et leurs utilisations dans le traitement du paludisme
US6790863B2 (en) * 2002-10-15 2004-09-14 University Of Mississippi Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents
US7842720B2 (en) * 2004-06-21 2010-11-30 Elsohly Laboratories, Incorporated Anticancer and antiprotozoal dihydroartemisinene and dihydroartemisitene dimers with desirable chemical functionalities
CN101125142A (zh) 2007-07-24 2008-02-20 北京中医药大学东直门医院 青蒿素在制备抗肿瘤多药耐药药物中的应用

Also Published As

Publication number Publication date
ES2367715T3 (es) 2011-11-07
MA30410B1 (fr) 2009-05-04
ATE512970T1 (de) 2011-07-15
HK1131779A1 (en) 2010-02-05
GT200800206A (es) 2008-12-04
CN101421276B (zh) 2012-11-14
FR2899586B1 (fr) 2008-06-20
MY154970A (en) 2015-08-28
SI2007769T1 (sl) 2011-10-28
AR060400A1 (es) 2008-06-11
AU2007235813A1 (en) 2007-10-18
KR20090009199A (ko) 2009-01-22
CY1111833T1 (el) 2015-10-07
BRPI0710152A2 (pt) 2011-08-02
MX2008012732A (es) 2008-10-17
WO2007116135A1 (fr) 2007-10-18
UY30276A1 (es) 2007-11-30
FR2899586A1 (fr) 2007-10-12
PT2007769E (pt) 2011-09-14
PE20080055A1 (es) 2008-03-24
ECSP088792A (es) 2008-11-27
UA94744C2 (ru) 2011-06-10
TWI423979B (zh) 2014-01-21
CA2641138C (fr) 2012-10-02
EA200870421A1 (ru) 2009-02-27
CR10247A (es) 2008-11-26
JP2009533398A (ja) 2009-09-17
TNSN08321A1 (en) 2009-12-29
TW200815456A (en) 2008-04-01
EP2007769A1 (fr) 2008-12-31
ME00094B (me) 2010-10-10
KR101357523B1 (ko) 2014-02-03
AU2007235813B2 (en) 2011-11-10
CA2641138A1 (fr) 2007-10-18
JP5265518B2 (ja) 2013-08-14
NO20084352L (no) 2008-10-16
HRP20110654T1 (hr) 2011-10-31
DK2007769T3 (da) 2011-10-03
EP2007769B1 (fr) 2011-06-15
IL194655A0 (en) 2009-08-03
JO2721B1 (en) 2013-09-15
US8314142B2 (en) 2012-11-20
MEP12308A (en) 2010-06-10
CN101421276A (zh) 2009-04-29
PL2007769T3 (pl) 2011-11-30
ZA200808025B (en) 2009-12-30
NZ571342A (en) 2011-01-28
US20090082426A1 (en) 2009-03-26
EA015607B1 (ru) 2011-10-31
RS51952B (en) 2012-02-29

Similar Documents

Publication Publication Date Title
HN2008001521A (es) Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica
NI201000005A (es) Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico.
GT201000023A (es) Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met.
SV2011003800A (es) Derivados de piridino-piridinonas, su preparacion y su aplicacion en terapeutica
UY31561A1 (es) Azolilmetiloxiranos, su uso y agentes que los contienen
CR11373A (es) COMPUESTOS DE TIENOPIRIMIDINA Y PIRAZOLOPIRIMIDINA Y SU USO COMO INHIBIDORES DE mTOR CINASA Y PI3 CINASA
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
UY31562A1 (es) Azolilmetiloxiranos, su uso y agentes que los contienen
UY31560A1 (es) Azolilmetiloxiranos, su uso y agentes que los contienen
UY31152A1 (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica
CR10603A (es) Derivados de 5,6-bisaril-2-piridin-carboxamida, su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de urotensina ii
HN2011002578A (es) Nuevos derivados de compuestos de [3,2-c]pirazol esteroidal con actividad clucocorticoide.
HN2010001537A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
UY31128A1 (es) Formulacion de nevirapina de liberacion prolongada
PA8661601A1 (es) Pirroles sustituidos, composiciones que los contienen, proceso de fabricacion y utilizacion
ECSP109874A (es) Nuevos compuestos 892
CR10390A (es) Derivados de 2-alcoxi-3,4,5-trihidroxi-alquilamida, su preparacion, composiciones que las contienen y utilizacion
DOP2012000146A (es) Nuevos derivados (heterociclo-tetrahidro-piridin)-(piperazinil)-1-alcanona y (heterociclo-dihidro-pirrolidin)-(piperazinil)-1-alcanona y su utilizacion como inhibidores de p75
UY30368A1 (es) 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzazepinas, su preparacion, composiciones que las contienen y utilizacion
GT200800254A (es) 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzotiazepinas, su preparacion, composiciones que las contienen y utilizacion.
SV2008003052A (es) Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica
DOP2005000246A (es) Indoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion